Skip to Content
Merck
  • Synthesis and Cytotoxicity Evaluation of DOTA-Conjugates of Ursolic Acid.

Synthesis and Cytotoxicity Evaluation of DOTA-Conjugates of Ursolic Acid.

Molecules (Basel, Switzerland) (2019-06-20)
Michael Kahnt, Sophie Hoenke, Lucie Fischer, Ahmed Al-Harrasi, René Csuk
ABSTRACT

In this study, we report the synthesis of several amine-spacered conjugates of ursolic acid (UA) and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA). Thus, a total of 11 UA-DOTA conjugates were prepared holding various oligo-methylene diamine spacers as well as different substituents at the acetate units of DOTA including tert-butyl, benzyl, and allyl esters. Furthermore, three synthetic approaches were compared for the ethylenediamine-spacered conjugate 29 regarding reaction steps, yields, and precursor availability. The prepared conjugates were investigated regarding cytotoxicity using SRB assays and a set of human tumor cell lines. The highest cytotoxicity was observed for piperazinyl spacered compound 22. Thereby, EC50 values of 1.5 µM (for A375 melanoma) and 1.7 µM (for A2780 ovarian carcinoma) were determined. Conjugates 22 and 24 were selected for further cytotoxicity investigations including fluorescence microscopy, annexin V assays and cell cycle analysis.